Morning Overview on MSN
New antibody stops one of the deadliest breast cancers
One of the most lethal forms of breast cancer has long shrugged off the best drugs in the oncologist’s arsenal, leaving patients with few options once standard treatments fail. Now a new generation of ...
Antibody-based therapies are used to treat numerous diseases, from cancer to rheumatic disorders and multiple sclerosis.
News-Medical.Net on MSN
Researchers decipher anti-MOG antibody construction, paving way for therapies
MOG Antibody-associated Disease (MOGAD) is a rare autoimmune disease of the central nervous system. The blood of patients ...
Researchers at Texas Biologics at The University of Texas at Austin, working with scientists internationally, have made an ...
Dr. Amany Keruakous sat down for an interview with CURE, in which she discussed how bispecific antibodies for multiple ...
The Brighterside of News on MSN
Antibody injections could replace slow IV drips in treating many diseases, MIT scientists find
Patients who depend on antibody drugs often spend long hours in infusion centers. These medicines are vital for treating many ...
Stacker on MSN
Achieving lasting remission for HIV
Knowable Magazine reports on breakthroughs in HIV treatment; engineered antibodies show promise for long-term control, ...
A newly engineered antibody can penetrate kidney cysts and interrupt the growth signals that drive polycystic kidney disease.
COVID-19 antibody drugs from Regeneron and Eli Lilly should no longer be used because they don't work against the omicron variant that now accounts for nearly all U.S. infections, U.S. health ...
The race is on for new treatments that stand up to omicron's explosive spread. With omicron's explosive spread threatening to outpace current COVID-19 treatments, the race is on to find new options ...
Scientists have uncovered a powerful new antibody that disrupts a key protein helping triple-negative breast cancer survive and evade immunity. Triple-negative breast cancer (TNBC) is considered one ...
One expert explains how bispecific antibodies are a ‘targeted and effective’ option for patients with multiple myeloma. Bispecific antibodies offer a “targeted and effective alternative” for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results